Featured Journal Content
COVID Vaccines/Therapeutics – Developer/Manufacturer Announcements
[Selected press releases/announcements from organizations from WHO EUL/PQ listing above and other organizations]
AstraZeneca
Press Releases
Evusheld long-acting antibody combination approved in the EU for pre-exposure prophylaxis (prevention) of COVID-19 in a broad population
28 March 2022
Bharat Biotech
Press Releases – No new digest announcements identified
BioCubaFarma – Cuba
Últimas Noticias – Website not leading at inquiry
Biological E
News – No new digest announcements identified
Biontech
Press Releases
Pfizer and BioNTech Receive Expanded U.S. Emergency Use Authorization for an Additional COVID-19 Vaccine Booster in Individuals Aged 50 Years and Older
29 Mar 2022
CanSinoBIO
News – Website not responding at inquiry
CIGB
Latest News
Purity and efficacy of Mambisa, the first anti-covid nasal vaccine (Part I)
09 Mar 2022
Cinagen
Recent News – No new digest announcements identified
Clover Biopharmaceuticals – China
News – No new digest announcements identified
Curevac [Bayer Ag – Germany]
News
March 30, 2022
CureVac and GSK Start Clinical Development of Second-Generation COVID-19 Vaccine Candidate, CV2CoV
Phase 1 dose-escalation study started at clinical sites in the U.S.
Milestone demonstrates CureVac’s and GSK’s continued execution on comprehensive clinical program of second-generation vaccine candidates for infectious diseases
Gamaleya National Center
Latest News and Events – See Russia below.
IMBCAMS, China
Home – Website not responding at inquiry
Janssen/JNJ
Press Releases
Mar 29, 2022 United States
U.S. FDA Approves CABENUVA (cabotegravir and rilpivirine) for Adolescents, Expanding the Indication of the First and Only Complete Long-Acting Injectable HIV Regimen
Medicago
Media
February 24, 2022
Medicago and GSK announce the approval by Health Canada of COVIFENZ®, an Adjuvanted Plant-Based COVID-19 Vaccine
Moderna
Press Releases
March 29, 2022
Moderna Receives FDA Approval for Emergency Use Authorization of 2nd Booster Dose of Its COVID-19 Vaccine, mRNA-1273
Nanogen
News – No new digest announcements identified
Novavax
Press Releases
Novavax Statement on Arrival of its COVID-19 Vaccine in Canada
Mar 31, 2022
Pfizer
Recent Press Releases
03.29.2022
Pfizer and BioNTech Receive Expanded U.S. Emergency Use Authorization for an Additional COVID-19 Vaccine Booster in Individuals Aged 50 Years and Older
R-Pharm
https://rpharm-us.com/index.php
[No news or media page identified]
Sanofi Pasteur
Press Releases – No new digest announcements identified
Serum Institute of India
NEWS & ANNOUNCEMENTS – No new digest announcements identified
Shifa Pharmed [Iran]
http://shafapharmed.com/
No news page identified.
Sinopharm/WIBPBIBP
News – No new digest announcements identified
Sinovac
Press Releases – No new digest announcements identified
Vector State Research Centre of Viralogy and Biotechnology
Home – No new digest announcements identified
WestVac Biopharma
Media – No new digest announcements identified
Zhifei Longcom, China
[Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd.]
[No website identified]
::::::
GSK
Press releases for media – No new digest announcements identified
Merck
News releases – No new digest announcements identified
Novartis
News – No new digest announcements identified
SK Biosciences
Press releases – Website not responding at inquiry
Valneva
Press Releases – No new digest announcements identified
vaccines and global health :: ethics and policy 